Yet, pCR is rarely obtained for the majority of HR-positive, HER2-negative breast cancers, and pCR is even less likely for large T3, as compared to smaller T1-2 primary tumors [64–66]. The gene discussed is ERBB2; the disease is breast carcinoma.